Download

Download Full Text (420 KB)

Contents

  • Neoadjuvant Immunotherapy for Melanoma: Trial investigates immune checkpoint blockade in patients with respectable stage III or oligometastatic stage IV disease.
  • Radiation May Enhance Immunotherapy for Solid Tumors: Clinical Trials combine immune checkpoint inhibitors with radiation therapy against lung cancers, other solid tumors.
  • INBRIEF: Nivolumab Plus Azacitidine Shows Promise in Relapsed Acute Myelogenous Leukemia/ Acute Myelogenous Leukemia, Myelodysplastic Syndrome Study Questions Standard Exclusion Criteria for Conventional Trials
  • HOUSE CALL: Social Media Groups for Cancer Patients-Twitter chats, online groups for patients, caregivers
  • USEFUL RESOURCES: Resources to Aid Referring Physicians

Publication Date

1-1-2017

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston, Texas

Keywords

Amaria, Rodabe; Wargo, Jennifer; Welsh, James; Daver, Naval; Garcia-Manero, Guillermo; Melanoma; Immunotherapy; Neoadjuvant Therapy; Clinical Trials as Topic; Neoplasms; Radiotherapy; Nivolumab; Azacitidine; Leukemia, Myeloid, Acute; Social Media; Social Support; Brain Neoplasms; Breast Neoplasms; Lung Neoplasms; Referral and Consultation.

Disciplines

History of Science, Technology, and Medicine | Oncology

Conditions Governing Access

Redacted

OncoLog, Volume 62, Number 01, January 2017

Share

COinS